METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING ISOINDOLINE DERIVATIVES

1. Compounds having the Formula 1: or the pharmaceutically acceptable salts thereof, wherein X is phenyl or substituted phenyl; Y is phenyl, substituted phenyl, pyridyl, or substituted pyridyl; wherein substituted phenyl and substituted pyridyl can have from 1 to 4 substituents, each independently s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LAI, YINGJIE, WALKER, LARY, CRASWELL, SAKKAB, ANNETTE, THERESE, AUGELLI-SZAFRAN, CORRINE, ELIZABETH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	1. Compounds having the Formula 1: or the pharmaceutically acceptable salts thereof, wherein X is phenyl or substituted phenyl; Y is phenyl, substituted phenyl, pyridyl, or substituted pyridyl; wherein substituted phenyl and substituted pyridyl can have from 1 to 4 substituents, each independently selected from -OC1-C12alkyl, halogen-C1-C6alkyl, phenyl, -CO2H, -CO2R , -NO2, -CF3, -CN, -NR R , -(CH2)nCO2H, -(CH2)nCO2R , -SO2NR R , tetrazole, -(CH2)n-tetrazole, decahydroisoquinoline, imidazole, -(CH2)n imidazole, -CH=CH tetrazole, -CH=CH-imidazole, or phenyl; R and R independently are hydrogen or C1-C6alkyl; and each n is independently 0 to 5 inclusive. R" is hydrogen, C1-C6alkyl, or phenyl; and R' is hydrogen, C1-C6alkyl, -CF3, or phenyl. 2. A compound in accordance with Claim 1, having formula or the pharmaceutically acceptable salts thereof, wherein X is phenyl or substituted phenyl; when X is substituted phenyl and the substituted phenyl has from 1 to 4 substituents independently selected from -OC1-C6alkyl, halogen, C1-C6alkyl, -CF3, or phenyl. Y is substituted phenyl and the substituted phenyl has from 1 to 4 substituents independently selected from -CO2H, -NO2, -OC1-C12 alkyl, -CN, -CF3, -(CH2)nCO2H, -SO2NR R , tetrazole, -(CH2)n-tetrazole, imidazole, (CH2)n imidazole, -CH=CH-tetrazole, or -CH=CH-imidazole. 3. The compounds according to claim 1: 2-[2-(2,3,4-Trimethoxy-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-benzoic acid; 5-Nitro-2-[2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 4-Methoxy-5-nitro-2-[2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-(3,4-Dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-(3,4-Dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-5-nitro-benzoic acid; 2-[2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-4-methoxy-5-nitro-benzoic acid; 2-[2-(3-Chlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-(4-Chlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-(3,4-Dimethylphenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-(4-Chloro-3-trifluoromethylphenyl)-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; 2-[2-Biphenyl-4-yl-2,3-dihydro-1H-isoindol-5-ylamino] benzoic acid; or 2-[2-(3-Chlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-5-nitro-benzoic acid. 4. The compounds according to claim 1: 2-[2-(3,4-Dimehtyl-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino] 5-nitro-benzoic acid; 2-(2-Phenyl-2,3-dihydro-1H-isoindo